October 6, 2010 -- China’s pharmaceutical market will grow at a CAGR of 13.7% in dollar terms over the next five years (2010-14), taking its combined sales of OTC and prescription drugs from $46.8 billion in 2009 to $88.7 billion in 2014. The jump equates to a 12.4% CAGR in local currency, which is lower because of an expected rise in the value of the yuan. The prediction was made by Business Monitor International. More details....
